The following is a summary of “Longitudinal Links between Changes in Body Composition and Liver Disease Severity in Children ...

The FDA has updated the prescribing information for Veozah (fezolinetant) to include a warning regarding the risk of serious liver injury.

The FDA has approved Kisqali (ribociclib) in adults with HR-positive, HER2-negative stage II and III early breast cancer.

A new prognostic model can predict and stratify hepatocellular carcinoma (HCC) risk in noncirrhotic adult patients with ...

Findings from the NATALEE trial show that the combination of Kisqali and an aromatase inhibitor resulted in disease-free ...

Additionally, AEs can include an increase in alanine aminotransferase, aspartate aminotransferase, infections, creatinine, headache, nausea, and fatigue. Patients with advanced or metastatic breast ...

"The interest and use of cannabis-based medicines has increased, including in children with complex health concerns like ...

Study found that higher soft drink consumption is associated with an increased risk of nonalcoholic fatty liver disease, ...

Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today a ...

Report on how AI is redefining market landscape- The global clinical chemistry analyzers market size is estimated to grow by ...

Zongertinib demonstrated activity in previously treated patients with HER2-mutant NSCLC enrolled in the Beamion LUNG-1 trial.